Women in STEM breaking barriers and advancing the future of regenerative medicine
Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration and the next era of regenerative medicine
Dr. Vasiliki E. Kalodimou on women in STEM, global collaboration and the next era of regenerative medicine
Guest editorial by Frank Sandulu, award-winning Biomedical Scientist and CEO, Biomed Connect
Guest Editorial by Stephanie Ibbotson, Senior Director, Strategic Marketing and Market Access, Diasorin
Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them
A new bench-top bioreactor platform with process control designed to support GMP-ready environments from 100 mL to 10 L working volume
Yale Professor Joe El-Khoury discusses Aletta, the ADOPT study and how autonomous blood collection could improve standardization, capacity, and quality across laboratory medicine
Irena Ivanova explores the potential of artificial intelligence to strengthen laboratory quality, efficiency and access to care while preserving human oversight and compassion
A validated bioassay that worked yesterday is not guaranteed to work tomorrow, and CRO Prolytix is urging the industry to rethink what ‘validated’ really means
Guest editorial written by Aida Noor, Biomedical Scientist, Founder of Biomedical Science & Beyond, CLINICAL24 Ambassador
Guest editorial by Russ Lebovitz, MD, PhD, is CEO and Co-Founder of Amprion
Guest editorial by Maya Carlyle, Principal AI Engineer at the National Physical Laboratory (NPL)
As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions
Uncover how ALS is readying its PFAS workflows for TFA and Europe's expanding surface and groundwater rules
Delivering reduced hands-on time, more consistent results, and higher sample throughput
PakScan brings configurable test layouts, low-headspace capability, and a smaller footprint to PACK EXPO International 2026
The non-invasive test could help clinicians identify women needing urgent hospital investigations while reassuring those unlikely to have womb cancer
Every cell biologist knows the feeling of staring at two identical experiments with different outcomes and wondering whether the answer lies in the biology or the handling
The two companies aim to strengthen disease awareness, support earlier assessment of the disease, and remove barriers to non-invasive testing
New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested
New tool integrates the entire flow cytometry workflow from panel design to data analysis in one system
IPN60330 is a bispecific antibody engaging MAIT cells, a subset of non-conventional T cells present throughout the body, and the clinically validated tumor antigen GPC3 to kill cancer cells across a variety of solid tumors
Leandro Neves, Senior Global Director of R&D Genomics at LGC, discusses the technologies, challenges, and opportunities shaping the future of genomic analysis
IBMS Chief Executive David Wells shares valuable insights on workforce, automation, and sustainable transformation